J P Morgan Chase & Co Reiterates “Buy” Rating for Roche Holding Ltd. (VTX:ROG)
J P Morgan Chase & Co reaffirmed their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a research note published on Friday. The firm currently has a price target on the healthcare company’s stock.
Several other analysts have also recently commented on the stock. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on shares of Roche Holding and gave the stock a buy rating in a research note on Friday, May 26th. Morgan Stanley set a CHF 290 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Monday, May 29th. Deutsche Bank AG set a CHF 273 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, June 6th. Societe Generale set a CHF 275 price objective on shares of Roche Holding and gave the company a neutral rating in a research note on Thursday, June 29th. Finally, Barclays PLC set a CHF 305 price objective on shares of Roche Holding and gave the company a buy rating in a research note on Tuesday, June 13th. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of CHF 271.08.
Roche Holding (VTX:ROG) opened at 244.90 on Friday. Roche Holding has a 12 month low of CHK 218.30 and a 12 month high of CHK 273.00. The company has a 50-day moving average price of CHK 246.64 and a 200 day moving average price of CHK 251.31. The stock has a market capitalization of CHK 208.96 billion and a price-to-earnings ratio of 20.69.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.